EBITDA Margin ratio Analysis of Marksans Pharma - Deep Dive


Latest FY EBITDA Margin
Period Ending - Mar-25

23.38


Very Good EBITDA Margin
Period Ending - Mar-24
23.38

Very Good EBITDA Margin
Growth
0 %
Trailing Twelve Months EBITDA Margin
Period Ending - Mar-25

21.17


Very Good EBITDA Margin
Most recent Quarter EBITDA Margin
Period Ending - Dec-25

23.91


Very Good EBITDA Margin
EBITDA Margin Analysis of Marksans Pharma
Ebitda Margin Ratio of Marksans Pharma with value of 21.17 means that its operating expenses are lower in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of Marksans Pharma with value of 23.91 means that its operating expenses are lower in relation to total revenue latest Quarter ending on Dec-25.
EBITDA Margin Ratio of MARKSANS has fallen by 0 % Compared to previous Financial Year.
EBITDA Margin Ratio with value of 25.16 was highest in Year Mar-21 in last Five Years.
EBITDA Margin Ratio with value of 20.17 was lowest in Year Mar-22 in last Five Years.
Latest EBITDA Margin Ratio with value of 23.38 is Greater than Average EBITDA Margin of 22.73 in last five years.
Other EBITDA Margin Related Info of MARKSANS that may interest you.
Marksans Pharma Overview
CodePricePrevious PricePrice ChangeSector
MARKSANS180.18178.920.704 % Health Services
Fundamental AnalysisTechnical Analysis
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization.   more ..
EBITDA Margin Formula
   EBITDA Margin Screener
EBITDA Margin Related Ratios
NetProfitMarginReturnOnEquity

Tsr Profitability Index
No Significant ProfitabilityScreener
FY - Historical EBITDA Margin of Marksans Pharma
PeriodMar-25Mar-24Mar-23Mar-22Mar-21Mar-20Mar-19
EBITDA Margin23.3823.3821.5820.1725.1616.6513.30
Change0 %8.34 %6.96 %-19.84 %51.17 %25.14 %46.05 %
Price222.47151.9070.4045.5049.9513.9024.95
Price Change46.46 %115.77 %54.73 %-8.91 %259.35 %-44.29 %-21.17 %
You are view first 7 Records. Log in to view all 21 in Premium view
FY Chart of EBITDA Margin of Marksans Pharma